speb/financial-data huggingface dataset:
CLNE income_statement (annual, 2025-12-31) — Selling General And Administration: 111838000.00
CLNE income_statement (quarterly, 2025-12-31) — Selling General And Administration: 30651000.00
CLNE balance_sheet (annual, 2025-12-31) — Share Issued: 219331992.00
CLNE balance_sheet (quarterly, 2025-12-31) — Share Issued: 219331992.00
CLNE income_statement (annual, 2025-12-31) — Special Income Charges: -64328000.00
CLNE income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
CLNE cash_flow (annual, 2025-12-31) — Stock Based Compensation: 74970000.00
CLNE cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 17087000.00
CLNE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 559421000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 559421000.00
CLNE balance_sheet (annual, 2025-12-31) — Tangible Book Value: 549525000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 549525000.00
CLNE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -836264.00
CLNE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CLNE income_statement (annual, 2025-12-31) — Tax Provision: -2820000.00
CLNE income_statement (quarterly, 2025-12-31) — Tax Provision: -35000.00
CLNE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.01
CLNE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CLNE balance_sheet (annual, 2025-12-31) — Taxes Receivable: 1026000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 1026000.00
CLNE balance_sheet (annual, 2025-12-31) — Total Assets: 1056716000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Total Assets: 1056716000.00
CLNE balance_sheet (annual, 2025-12-31) — Total Capitalization: 786148000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 786148000.00
CLNE balance_sheet (annual, 2025-12-31) — Total Debt: 325628000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Total Debt: 325628000.00
CLNE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 565067000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 565067000.00
CLNE income_statement (annual, 2025-12-31) — Total Expenses: 520369000.00
CLNE income_statement (quarterly, 2025-12-31) — Total Expenses: 123017000.00
CLNE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 491649000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 491649000.00
CLNE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 706377000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 706377000.00
CLNE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 340494000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 340494000.00
CLNE income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -159864000.00
CLNE income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -10698000.00
CLNE income_statement (annual, 2025-12-31) — Total Unusual Items: -64328000.00
CLNE income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
CLNE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -64328000.00
CLNE income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CLNE balance_sheet (annual, 2025-12-31) — Working Capital: 199184000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Working Capital: 199184000.00
CLNE income_statement (annual, 2025-12-31) — Write Off: 0.00
CLNE income_statement (quarterly, 2026-03-31) — +Operating Expense: 24546000.00
CLNE income_statement (quarterly, 2026-03-31) — +Total Revenue: 117556000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 22211000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 110566000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -503558000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1808053000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1953000.00
CLNE cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 0.00
CLNE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 219667732.00
CLNE income_statement (quarterly, 2026-03-31) — Basic EPS: -0.06
CLNE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 157756000.00
CLNE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -7072000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 96046000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 22000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 55485000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 126240000.00
CLNE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -1950000.00
CLNE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -89610000.00
CLNE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -8362000.00
CLNE cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -3897000.00
CLNE cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -9521000.00
CLNE cash_flow (quarterly, 2026-03-31) — Change In Inventory: 756000.00
CLNE cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -2364000.00
CLNE cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -2873000.00
CLNE cash_flow (quarterly, 2026-03-31) — Change In Payable: -3897000.00
CLNE cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -13418000.00
CLNE cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -422000.00
CLNE cash_flow (quarterly, 2026-03-31) — Change In Receivables: -9046000.00
CLNE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -27367000.00
CLNE cash_flow (quarterly, 2026-03-31) — Changes In Cash: -99922000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Common Stock: 22000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 558142000.00
CLNE cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
CLNE cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
CLNE balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 42473000.00
CLNE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 95905000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 82552000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Current Assets: 332257000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 10587000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Current Debt: 54000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 10641000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 15550000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 15550000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 135029000.00
CLNE cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 0.00
CLNE cash_flow (quarterly, 2026-03-31) — Deferred Tax: 0.00
CLNE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 11002000.00
CLNE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 11002000.00
CLNE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 219667732.00
CLNE income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.06
CLNE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -12412000.00
CLNE income_statement (quarterly, 2026-03-31) — EBIT: -6808000.00
CLNE income_statement (quarterly, 2026-03-31) — EBITDA: 4194000.00
CLNE income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: -5638000.00
CLNE cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 5638000.00
CLNE cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -177000.00
CLNE cash_flow (quarterly, 2026-03-31) — End Cash Position: 57657000.00
CLNE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -1950000.00
CLNE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -15434000.00
CLNE cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -616000.00
CLNE cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 145000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -2955000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 9771000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 112519000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 907540000.00
CLNE income_statement (quarterly, 2026-03-31) — Gross Profit: 21651000.00
CLNE income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: 0.00
CLNE cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 2000.00
CLNE income_statement (quarterly, 2026-03-31) — Interest Expense: 5701000.00
CLNE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 5701000.00
CLNE income_statement (quarterly, 2026-03-31) — Interest Income: 1382000.00
CLNE income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1382000.00
CLNE cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 4570000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Interest Payable: 1438000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Inventory: 42683000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 786049000.00
CLNE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -89610000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 270291000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 270291000.00
CLNE cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
CLNE balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 20504000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Loans Receivable: 87000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 85459000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 227853000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 313312000.00
CLNE cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -336000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 270291000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 241143000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Minority Interest: 5531000.00
CLNE income_statement (quarterly, 2026-03-31) — Minority Interests: 115000.00
CLNE cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -12818000.00
CLNE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
CLNE balance_sheet (quarterly, 2026-03-31) — Net Debt: 172422000.00
CLNE income_statement (quarterly, 2026-03-31) — Net Income: -12412000.00
CLNE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -12412000.00
CLNE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -12527000.00
CLNE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -12412000.00
CLNE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -12412000.00
CLNE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -12527000.00
CLNE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -12527000.00
CLNE income_statement (quarterly, 2026-03-31) — Net Interest Income: -4319000.00
CLNE cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -69757000.00
CLNE cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -336000.00
CLNE cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -336000.00
CLNE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -4319000.00
CLNE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1614000.00
CLNE cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 21000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Net PPE: 403982000.00
CLNE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -7056000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 548371000.00
CLNE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 4194000.00
CLNE income_statement (quarterly, 2026-03-31) — Normalized Income: -12412000.00
CLNE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -8362000.00
CLNE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 5167000.00
CLNE income_statement (quarterly, 2026-03-31) — Operating Income: -2895000.00
CLNE income_statement (quarterly, 2026-03-31) — Operating Revenue: 117556000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 220224634.00
CLNE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 44115000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 54000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -2955000.00
CLNE income_statement (quarterly, 2026-03-31) — Other Income Expense: -5295000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 9771000.00
CLNE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 3088000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 20540000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 24827000.00
CLNE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 343000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Other Properties: 603420000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Other Receivables: 5368000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 70755000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Payables: 22211000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 104763000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 4075000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CLNE income_statement (quarterly, 2026-03-31) — Pretax Income: -12509000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CLNE cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 138000.00
CLNE cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -13271000.00
CLNE cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -159999000.00
CLNE cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -7072000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Raw Materials: 42683000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Receivables: 117047000.00
CLNE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 95905000.00
CLNE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 11002000.00
CLNE cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -336000.00
CLNE cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
CLNE balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 2172000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1246978000.00
CLNE cash_flow (quarterly, 2026-03-31) — Sale Of Business: 453000.00
CLNE cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 90242000.00
CLNE cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 16000.00
CLNE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 24546000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Share Issued: 220224634.00
CLNE income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
CLNE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 12137000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 558142000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 548371000.00
CLNE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CLNE income_statement (quarterly, 2026-03-31) — Tax Provision: 18000.00
CLNE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CLNE balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 1026000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Total Assets: 1036841000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 785995000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Total Debt: 323953000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 563673000.00
CLNE income_statement (quarterly, 2026-03-31) — Total Expenses: 120451000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 473168000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 704584000.00
CLNE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 338139000.00
CLNE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -2895000.00
CLNE income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
CLNE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CLNE balance_sheet (quarterly, 2026-03-31) — Working Capital: 197228000.00
CLNN balance_sheet (annual, 2021-12-31) — Cash Financial: 50288000.00
CLNN cash_flow (annual, 2021-12-31) — Change In Income Tax Payable: -164000.00
CLNN cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -260000.00
CLNN cash_flow (annual, 2021-12-31) — Change In Tax Payable: -164000.00
CLNN cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -2435000.00
CLNN cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 0.00
CLNN balance_sheet (annual, 2021-12-31) — Other Inventories: 1000.00
CLNN balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 20417000.00
CLNN income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -12000.00
CLNN balance_sheet (annual, 2021-12-31) — Other Receivables: 1564000.00
CLNN balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 0.00
CLNN income_statement (annual, 2021-12-31) — Other Special Charges: -648000.00
CLNN cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 0.00
CLNN income_statement (annual, 2022-12-31) — +Operating Expense: 45004000.00
CLNN income_statement (annual, 2022-12-31) — +Total Revenue: 473000.00
CLNN balance_sheet (annual, 2022-12-31) — Accounts Payable: 3014000.00
CLNN balance_sheet (annual, 2022-12-31) — Accounts Receivable: 189000.00
CLNN balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -5273000.00
CLNN balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 196246000.00
CLNN income_statement (annual, 2022-12-31) — Basic Average Shares: 3260233.00
CLNN income_statement (annual, 2022-12-31) — Basic EPS: -9.20
CLNN cash_flow (annual, 2022-12-31) — Beginning Cash Position: 50346000.00
CLNN cash_flow (annual, 2022-12-31) — Capital Expenditure: -5179000.00
CLNN balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 6153000.00
CLNN balance_sheet (annual, 2022-12-31) — Capital Stock: 7000.00
CLNN balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 18332000.00
CLNN balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 23315000.00
CLNN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 17249000.00
CLNN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -10164000.00
CLNN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -39011000.00
CLNN cash_flow (annual, 2022-12-31) — Change In Account Payable: 285000.00
CLNN cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 253000.00
CLNN cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 0.00
CLNN cash_flow (annual, 2022-12-31) — Change In Inventory: -2000.00
CLNN cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -493000.00
CLNN cash_flow (annual, 2022-12-31) — Change In Payable: 285000.00
CLNN cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 538000.00
CLNN cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -1443000.00
CLNN cash_flow (annual, 2022-12-31) — Change In Receivables: -140000.00
CLNN cash_flow (annual, 2022-12-31) — Change In Tax Payable: 0.00
CLNN cash_flow (annual, 2022-12-31) — Change In Working Capital: -1540000.00
CLNN cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -140000.00
CLNN cash_flow (annual, 2022-12-31) — Changes In Cash: -31926000.00
CLNN balance_sheet (annual, 2022-12-31) — Common Stock: 7000.00
CLNN balance_sheet (annual, 2022-12-31) — Common Stock Equity: 3237000.00
CLNN cash_flow (annual, 2022-12-31) — Common Stock Issuance: 11460000.00
CLNN balance_sheet (annual, 2022-12-31) — Construction In Progress: 5664000.00
CLNN income_statement (annual, 2022-12-31) — Cost Of Revenue: 26000.00
CLNN balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 1856000.00
CLNN balance_sheet (annual, 2022-12-31) — Current Assets: 29195000.00
CLNN balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 562000.00
CLNN balance_sheet (annual, 2022-12-31) — Current Debt: 6418000.00
CLNN balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 6980000.00
CLNN balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 520000.00
CLNN balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 520000.00
CLNN balance_sheet (annual, 2022-12-31) — Current Liabilities: 13857000.00
CLNN cash_flow (annual, 2022-12-31) — Depreciation: 1019000.00
CLNN cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1019000.00
CLNN cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1019000.00
CLNN balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
CLNN income_statement (annual, 2022-12-31) — Diluted Average Shares: 3260233.00
CLNN income_statement (annual, 2022-12-31) — Diluted EPS: -9.20
CLNN income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -29918000.00
CLNN income_statement (annual, 2022-12-31) — EBIT: -26622000.00
CLNN income_statement (annual, 2022-12-31) — EBITDA: -25603000.00
CLNN cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -30000.00
CLNN cash_flow (annual, 2022-12-31) — End Cash Position: 18390000.00
CLNN cash_flow (annual, 2022-12-31) — Financing Cash Flow: 17249000.00
CLNN balance_sheet (annual, 2022-12-31) — Finished Goods: 14000.00
CLNN cash_flow (annual, 2022-12-31) — Free Cash Flow: -44190000.00
CLNN cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -167000.00
CLNN income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 169000.00
CLNN balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 203000.00
CLNN income_statement (annual, 2022-12-31) — General And Administrative Expense: 16163000.00
CLNN balance_sheet (annual, 2022-12-31) — Gross PPE: 20513000.00
CLNN income_statement (annual, 2022-12-31) — Gross Profit: 447000.00
CLNN income_statement (annual, 2022-12-31) — Insurance And Claims: 3395000.00
CLNN income_statement (annual, 2022-12-31) — Interest Expense: 3296000.00
CLNN income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 3296000.00
CLNN income_statement (annual, 2022-12-31) — Interest Income: 225000.00
CLNN income_statement (annual, 2022-12-31) — Interest Income Non Operating: 225000.00
CLNN cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 2320000.00
CLNN balance_sheet (annual, 2022-12-31) — Inventory: 43000.00
CLNN balance_sheet (annual, 2022-12-31) — Invested Capital: 28908000.00
CLNN cash_flow (annual, 2022-12-31) — Investing Cash Flow: -10164000.00
CLNN cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 11460000.00
CLNN cash_flow (annual, 2022-12-31) — Issuance Of Debt: 5695000.00
CLNN balance_sheet (annual, 2022-12-31) — Leases: 5677000.00
CLNN balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 5591000.00
CLNN balance_sheet (annual, 2022-12-31) — Long Term Debt: 19253000.00
CLNN balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 24844000.00
CLNN cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 5695000.00
CLNN cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -135000.00
CLNN balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 636000.00
CLNN cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 11460000.00
CLNN balance_sheet (annual, 2022-12-31) — Net Debt: 7339000.00
CLNN income_statement (annual, 2022-12-31) — Net Income: -29918000.00
CLNN income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -29918000.00
CLNN income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -29918000.00
CLNN income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -29918000.00
CLNN income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -29918000.00
CLNN cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -29918000.00
CLNN income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -29918000.00
CLNN income_statement (annual, 2022-12-31) — Net Interest Income: -3844000.00
CLNN cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -4985000.00
CLNN cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 5560000.00
CLNN cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 5560000.00
CLNN income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -3844000.00
CLNN cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -81000.00
CLNN balance_sheet (annual, 2022-12-31) — Net PPE: 15240000.00
CLNN cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -5179000.00
CLNN balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 3237000.00
CLNN income_statement (annual, 2022-12-31) — Normalized EBITDA: -44054000.00
CLNN income_statement (annual, 2022-12-31) — Normalized Income: -48369000.00
CLNN cash_flow (annual, 2022-12-31) — Operating Cash Flow: -39011000.00
CLNN cash_flow (annual, 2022-12-31) — Operating Gains Losses: -167000.00
CLNN income_statement (annual, 2022-12-31) — Operating Income: -44557000.00
CLNN income_statement (annual, 2022-12-31) — Operating Revenue: 473000.00
CLNN balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 3737979.00
CLNN balance_sheet (annual, 2022-12-31) — Other Current Assets: 581000.00
CLNN balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 6418000.00
CLNN balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 203000.00
CLNN income_statement (annual, 2022-12-31) — Other Gand A: 2871000.00
CLNN income_statement (annual, 2022-12-31) — Other Income Expense: 18483000.00
CLNN cash_flow (annual, 2022-12-31) — Other Non Cash Items: -16918000.00
CLNN balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 58000.00
CLNN balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 2555000.00
CLNN income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 32000.00
CLNN income_statement (annual, 2022-12-31) — Other Operating Expenses: -3079000.00
CLNN balance_sheet (annual, 2022-12-31) — Other Properties: 8536000.00
CLNN balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 4983000.00
CLNN income_statement (annual, 2022-12-31) — Other Special Charges: -420000.00
CLNN balance_sheet (annual, 2022-12-31) — Payables: 3014000.00
CLNN balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 4870000.00
CLNN balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2007000.00
CLNN balance_sheet (annual, 2022-12-31) — Prepaid Assets: 2290000.00
CLNN income_statement (annual, 2022-12-31) — Pretax Income: -29918000.00
CLNN cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 310000.00
CLNN balance_sheet (annual, 2022-12-31) — Properties: 0.00
CLNN cash_flow (annual, 2022-12-31) — Purchase Of Investment: -24614000.00
CLNN cash_flow (annual, 2022-12-31) — Purchase Of PPE: -5179000.00
CLNN balance_sheet (annual, 2022-12-31) — Raw Materials: 29000.00
CLNN balance_sheet (annual, 2022-12-31) — Receivables: 2966000.00
CLNN income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 26000.00
CLNN income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1019000.00
CLNN cash_flow (annual, 2022-12-31) — Repayment Of Debt: -135000.00
CLNN income_statement (annual, 2022-12-31) — Research And Development: 31920000.00
CLNN income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: -17862000.00
CLNN balance_sheet (annual, 2022-12-31) — Retained Earnings: -193219000.00
CLNN income_statement (annual, 2022-12-31) — Salaries And Wages: 9897000.00
CLNN cash_flow (annual, 2022-12-31) — Sale Of Investment: 19629000.00
CLNN income_statement (annual, 2022-12-31) — Selling General And Administration: 16163000.00
CLNN balance_sheet (annual, 2022-12-31) — Share Issued: 3737979.00
CLNN income_statement (annual, 2022-12-31) — Special Income Charges: 18282000.00
CLNN cash_flow (annual, 2022-12-31) — Stock Based Compensation: 8513000.00
CLNN balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3237000.00
CLNN balance_sheet (annual, 2022-12-31) — Tangible Book Value: 3237000.00
CLNN income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CLNN income_statement (annual, 2022-12-31) — Tax Provision: 0.00
CLNN income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CLNN balance_sheet (annual, 2022-12-31) — Taxes Receivable: 2777000.00
CLNN balance_sheet (annual, 2022-12-31) — Total Assets: 44493000.00
CLNN balance_sheet (annual, 2022-12-31) — Total Capitalization: 22490000.00
CLNN balance_sheet (annual, 2022-12-31) — Total Debt: 31824000.00
CLNN balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3237000.00
CLNN income_statement (annual, 2022-12-31) — Total Expenses: 45030000.00
CLNN balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 41256000.00
CLNN balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 15298000.00
CLNN balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 27399000.00
CLNN income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -48409000.00
CLNN income_statement (annual, 2022-12-31) — Total Other Finance Cost: 773000.00
CLNN income_statement (annual, 2022-12-31) — Total Unusual Items: 18451000.00
CLNN income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 18451000.00
CLNN balance_sheet (annual, 2022-12-31) — Working Capital: 15338000.00
CLNN income_statement (annual, 2023-12-31) — +Operating Expense: 38793000.00
CLNN income_statement (annual, 2023-12-31) — +Total Revenue: 654000.00
CLNN balance_sheet (annual, 2023-12-31) — Accounts Payable: 1504000.00
CLNN balance_sheet (annual, 2023-12-31) — Accounts Receivable: 143000.00
CLNN balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -6887000.00
CLNN balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 255913000.00
CLNN income_statement (annual, 2023-12-31) — Basic Average Shares: 5246941.00
CLNN income_statement (annual, 2023-12-31) — Basic EPS: -9.43
CLNN cash_flow (annual, 2023-12-31) — Beginning Cash Position: 18390000.00
CLNN cash_flow (annual, 2023-12-31) — Capital Expenditure: -330000.00
CLNN balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 5506000.00
CLNN balance_sheet (annual, 2023-12-31) — Capital Stock: 1000.00
CLNN balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 28821000.00
CLNN balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 35000000.00
CLNN balance_sheet (annual, 2023-12-31) — Cash Equivalents: 24997000.00
CLNN balance_sheet (annual, 2023-12-31) — Cash Financial: 3824000.00
CLNN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 42163000.00
CLNN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -1499000.00
CLNN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -30171000.00
CLNN cash_flow (annual, 2023-12-31) — Change In Account Payable: -1510000.00
CLNN cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -143000.00
CLNN cash_flow (annual, 2023-12-31) — Change In Inventory: 6000.00
CLNN cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -566000.00
CLNN cash_flow (annual, 2023-12-31) — Change In Payable: -1510000.00
CLNN cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -1653000.00
CLNN cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 1976000.00
CLNN cash_flow (annual, 2023-12-31) — Change In Receivables: 46000.00
CLNN cash_flow (annual, 2023-12-31) — Change In Working Capital: -191000.00
CLNN cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 46000.00
CLNN cash_flow (annual, 2023-12-31) — Changes In Cash: 10493000.00
CLNN balance_sheet (annual, 2023-12-31) — Common Stock: 1000.00
CLNN balance_sheet (annual, 2023-12-31) — Common Stock Equity: 13390000.00
CLNN cash_flow (annual, 2023-12-31) — Common Stock Issuance: 42094000.00
CLNN balance_sheet (annual, 2023-12-31) — Construction In Progress: 1438000.00
CLNN income_statement (annual, 2023-12-31) — Cost Of Revenue: 121000.00
CLNN balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1162000.00
CLNN balance_sheet (annual, 2023-12-31) — Current Assets: 38852000.00
CLNN balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 603000.00
CLNN balance_sheet (annual, 2023-12-31) — Current Debt: 19503000.00
CLNN balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 20106000.00
CLNN balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 438000.00
CLNN balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 438000.00
CLNN balance_sheet (annual, 2023-12-31) — Current Liabilities: 25330000.00
CLNN cash_flow (annual, 2023-12-31) — Depreciation: 1705000.00
CLNN cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1705000.00
CLNN income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 267000.00
CLNN cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1705000.00
CLNN income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 267000.00
CLNN income_statement (annual, 2023-12-31) — Depreciation Income Statement: 267000.00
CLNN balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 1481000.00
CLNN income_statement (annual, 2023-12-31) — Diluted Average Shares: 5246941.00
CLNN income_statement (annual, 2023-12-31) — Diluted EPS: -9.43
CLNN income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -49504000.00
CLNN income_statement (annual, 2023-12-31) — EBIT: -44946000.00
CLNN income_statement (annual, 2023-12-31) — EBITDA: -43241000.00
CLNN cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -4000.00
CLNN cash_flow (annual, 2023-12-31) — End Cash Position: 28879000.00
CLNN cash_flow (annual, 2023-12-31) — Financing Cash Flow: 42163000.00
CLNN balance_sheet (annual, 2023-12-31) — Finished Goods: 14000.00
CLNN cash_flow (annual, 2023-12-31) — Free Cash Flow: -30501000.00
CLNN cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -6337000.00
CLNN cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
CLNN income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 6337000.00
CLNN balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 199000.00
CLNN income_statement (annual, 2023-12-31) — General And Administrative Expense: 12834000.00
CLNN balance_sheet (annual, 2023-12-31) — Gross PPE: 20318000.00
CLNN income_statement (annual, 2023-12-31) — Gross Profit: 533000.00
CLNN income_statement (annual, 2023-12-31) — Insurance And Claims: 1593000.00
CLNN income_statement (annual, 2023-12-31) — Interest Expense: 4558000.00
CLNN income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 4558000.00
CLNN income_statement (annual, 2023-12-31) — Interest Income: 1389000.00
CLNN income_statement (annual, 2023-12-31) — Interest Income Non Operating: 1389000.00
CLNN cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 3059000.00
CLNN balance_sheet (annual, 2023-12-31) — Inventory: 37000.00
CLNN balance_sheet (annual, 2023-12-31) — Invested Capital: 40045000.00
CLNN cash_flow (annual, 2023-12-31) — Investing Cash Flow: -1499000.00
CLNN cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 42094000.00
CLNN cash_flow (annual, 2023-12-31) — Issuance Of Debt: 350000.00
CLNN balance_sheet (annual, 2023-12-31) — Leases: 9983000.00
CLNN balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 4903000.00
CLNN balance_sheet (annual, 2023-12-31) — Long Term Debt: 7152000.00
CLNN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 12055000.00
CLNN cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 350000.00
CLNN cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -81000.00
CLNN balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 637000.00
CLNN cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 42094000.00
CLNN income_statement (annual, 2023-12-31) — Net Income: -49504000.00
CLNN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -49504000.00
CLNN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -49504000.00
CLNN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -49504000.00
CLNN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -49504000.00
CLNN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -49504000.00
CLNN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -49504000.00
CLNN income_statement (annual, 2023-12-31) — Net Interest Income: -4486000.00
CLNN cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -1169000.00
CLNN cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 269000.00
CLNN cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 269000.00
CLNN income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -4486000.00
CLNN cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -200000.00
CLNN balance_sheet (annual, 2023-12-31) — Net PPE: 13431000.00
CLNN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -330000.00
CLNN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 13390000.00
CLNN income_statement (annual, 2023-12-31) — Normalized EBITDA: -52048000.00
CLNN income_statement (annual, 2023-12-31) — Normalized Income: -58311000.00
CLNN cash_flow (annual, 2023-12-31) — Operating Cash Flow: -30171000.00
CLNN cash_flow (annual, 2023-12-31) — Operating Gains Losses: -6337000.00
CLNN income_statement (annual, 2023-12-31) — Operating Income: -38260000.00
CLNN income_statement (annual, 2023-12-31) — Operating Revenue: 654000.00
CLNN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 6421142.00
CLNN balance_sheet (annual, 2023-12-31) — Other Current Assets: 568000.00
CLNN balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 19503000.00
CLNN balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 199000.00
CLNN income_statement (annual, 2023-12-31) — Other Gand A: 1946000.00
CLNN income_statement (annual, 2023-12-31) — Other Income Expense: -6758000.00
CLNN cash_flow (annual, 2023-12-31) — Other Non Cash Items: 15039000.00
CLNN balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 58000.00
CLNN balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 85000.00
CLNN income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -15565000.00
CLNN income_statement (annual, 2023-12-31) — Other Operating Expenses: -963000.00
CLNN balance_sheet (annual, 2023-12-31) — Other Properties: 8260000.00
CLNN balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 6179000.00
CLNN balance_sheet (annual, 2023-12-31) — Payables: 1504000.00
CLNN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 2666000.00
CLNN balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2120000.00
CLNN balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1909000.00
CLNN income_statement (annual, 2023-12-31) — Pretax Income: -49504000.00
CLNN cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
CLNN balance_sheet (annual, 2023-12-31) — Properties: 0.00
CLNN cash_flow (annual, 2023-12-31) — Purchase Of Investment: -6169000.00
CLNN cash_flow (annual, 2023-12-31) — Purchase Of PPE: -330000.00
CLNN balance_sheet (annual, 2023-12-31) — Raw Materials: 23000.00
CLNN balance_sheet (annual, 2023-12-31) — Receivables: 1338000.00
CLNN income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 121000.00
CLNN income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1705000.00
CLNN cash_flow (annual, 2023-12-31) — Repayment Of Debt: -81000.00
CLNN income_statement (annual, 2023-12-31) — Research And Development: 26655000.00
CLNN income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: -2470000.00
CLNN balance_sheet (annual, 2023-12-31) — Retained Earnings: -242723000.00
CLNN income_statement (annual, 2023-12-31) — Salaries And Wages: 9295000.00
CLNN cash_flow (annual, 2023-12-31) — Sale Of Investment: 5000000.00
CLNN income_statement (annual, 2023-12-31) — Selling General And Administration: 12834000.00
CLNN balance_sheet (annual, 2023-12-31) — Share Issued: 6421142.00
CLNN income_statement (annual, 2023-12-31) — Special Income Charges: 2470000.00
CLNN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 9117000.00
CLNN balance_sheet (annual, 2023-12-31) — Stockholders Equity: 13390000.00
CLNN balance_sheet (annual, 2023-12-31) — Tangible Book Value: 13390000.00
CLNN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CLNN income_statement (annual, 2023-12-31) — Tax Provision: 0.00
CLNN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CLNN balance_sheet (annual, 2023-12-31) — Taxes Receivable: 1195000.00
CLNN balance_sheet (annual, 2023-12-31) — Total Assets: 52341000.00
CLNN balance_sheet (annual, 2023-12-31) — Total Capitalization: 20542000.00
CLNN balance_sheet (annual, 2023-12-31) — Total Debt: 32161000.00
CLNN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 13390000.00
CLNN income_statement (annual, 2023-12-31) — Total Expenses: 38914000.00
CLNN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 38951000.00
CLNN balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 13489000.00
CLNN balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 13621000.00
CLNN income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -40540000.00
CLNN income_statement (annual, 2023-12-31) — Total Other Finance Cost: 1317000.00
CLNN income_statement (annual, 2023-12-31) — Total Unusual Items: 8807000.00
CLNN income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 8807000.00
CLNN balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CLNN balance_sheet (annual, 2023-12-31) — Working Capital: 13522000.00
CLNN income_statement (quarterly, 2024-09-30) — Basic Average Shares: 6557839.00
CLNN income_statement (quarterly, 2024-09-30) — Basic EPS: -1.22
CLNN cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -1000.00
CLNN income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 6557839.00
CLNN income_statement (quarterly, 2024-09-30) — Diluted EPS: -1.22
CLNN cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
CLNN cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
CLNN balance_sheet (quarterly, 2024-09-30) — Other Payable: 3810000.00
CLNN balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 0.00
CLNN cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 88000.00
CLNN income_statement (annual, 2024-12-31) — +Operating Expense: 32247000.00
CLNN income_statement (annual, 2024-12-31) — +Total Revenue: 342000.00
CLNN balance_sheet (annual, 2024-12-31) — Accounts Payable: 1240000.00
CLNN balance_sheet (annual, 2024-12-31) — Accounts Receivable: 64000.00
CLNN balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -7876000.00
CLNN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 273194000.00
CLNN income_statement (annual, 2024-12-31) — Basic Average Shares: 6954133.00
CLNN income_statement (annual, 2024-12-31) — Basic EPS: -5.67
CLNN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 28879000.00
CLNN cash_flow (annual, 2024-12-31) — Capital Expenditure: -15000.00
CLNN cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -1000.00
CLNN balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 5058000.00
CLNN balance_sheet (annual, 2024-12-31) — Capital Stock: 1000.00
CLNN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 12155000.00
CLNN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 12155000.00
CLNN balance_sheet (annual, 2024-12-31) — Cash Equivalents: 7002000.00
CLNN balance_sheet (annual, 2024-12-31) — Cash Financial: 5153000.00
CLNN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -1529000.00
CLNN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 6316000.00
CLNN cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -2000.00
CLNN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -21326000.00
CLNN cash_flow (annual, 2024-12-31) — Change In Account Payable: -264000.00
CLNN cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 4046000.00
CLNN cash_flow (annual, 2024-12-31) — Change In Inventory: -31000.00
CLNN cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -421000.00
CLNN cash_flow (annual, 2024-12-31) — Change In Payable: -264000.00
CLNN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 3782000.00
CLNN cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -198000.00
CLNN cash_flow (annual, 2024-12-31) — Change In Receivables: 79000.00
CLNN cash_flow (annual, 2024-12-31) — Change In Working Capital: 3211000.00
CLNN cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 79000.00
CLNN cash_flow (annual, 2024-12-31) — Changes In Cash: -16539000.00
CLNN balance_sheet (annual, 2024-12-31) — Common Stock: 1000.00
CLNN balance_sheet (annual, 2024-12-31) — Common Stock Equity: -8857000.00
CLNN cash_flow (annual, 2024-12-31) — Common Stock Issuance: 9243000.00
CLNN balance_sheet (annual, 2024-12-31) — Construction In Progress: 1298000.00
CLNN income_statement (annual, 2024-12-31) — Cost Of Revenue: 70000.00
CLNN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 1022000.00
CLNN balance_sheet (annual, 2024-12-31) — Current Assets: 16157000.00
CLNN balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 926000.00
CLNN balance_sheet (annual, 2024-12-31) — Current Debt: 359000.00
CLNN balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1285000.00
CLNN balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 2665000.00
CLNN balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 2665000.00
CLNN balance_sheet (annual, 2024-12-31) — Current Liabilities: 10291000.00
CLNN cash_flow (annual, 2024-12-31) — Depreciation: 1645000.00
CLNN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1645000.00
CLNN income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 266000.00
CLNN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1645000.00
CLNN income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 266000.00
CLNN income_statement (annual, 2024-12-31) — Depreciation Income Statement: 266000.00
CLNN balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 6345000.00